| Individual Articles - Jan/Feb 1999 - Dental Compounding |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Issues and Opportunities: Compounding for Dentistry
Marek Cindy L
|
Jan/Feb 1999
Pg. 4
|
Compounding Mouthwashes and Rinses for Oral Ulcerations
Paoletti James E, McCord Kayda
|
Jan/Feb 1999
Pg. 8
|
Oral Ulceration Mouthwash
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 10
|
Mouthwash, Toothpaste and Toothgel Vehicles
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 12-13
|
Mouthwash/Gargle Formulation No. 1
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 12
|
Mouthwash/Gargle Formulation No. 2
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 12
|
Mouthwash/Gargle Formulation No. 3
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 12
|
Toothgel Vehicle
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 13
|
Toothpaste Vehicle
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 13
|
Toxicity of Amalgams
Fenrich Jon
|
Jan/Feb 1999
Pg. 14
|
A Brief Look at the History of Oral Hygiene
Capps Shelly
|
Jan/Feb 1999
Pg. 17
|
Dental Compounding in Denmark
Petersen Jens Kelsen
|
Jan/Feb 1999
Pg. 18-19
|
The Basics of Compounding: Compounding Ointments and Pastes
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 22-24
|
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 25-29
|
Coenzyme Q10: It's Everywhere
Hudson Sonora
|
Jan/Feb 1999
Pg. 30-33
|
Ubidicarenone (Coenzyme Q10) 200-mg Gelatin Troche
Roentsch George
|
Jan/Feb 1999
Pg. 32
|
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Mason Dave
|
Jan/Feb 1999
Pg. 34-35
|
Audit Problems for Compounding Pharmacies
Heckman H Edward
|
Jan/Feb 1999
Pg. 36-37
|
HRT Marketing Tip
|
Jan/Feb 1999
Pg. 37
|
Ringworms in Cats
Franck Paul W, Allen Cheryl, Thomasson Alex
|
Jan/Feb 1999
Pg. 38
|
Profile of a Practice
Davis Jeanie Lerche
|
Jan/Feb 1999
Pg. 39
|
Dental Cavity Varnish
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 42
|
Dental Chemical Curettage Agent
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 43
|
Dental Pressure Indicating Paste (PIP)
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 44
|
Fluoride Lozenges
Mason Dave
|
Jan/Feb 1999
Pg. 45
|
Gag Tablet
Ford Peter R
|
Jan/Feb 1999
Pg. 46
|
Gum Massage Gel
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 47
|
Misoprostol 0.0024% and Lidocaine 1% in Glycerin Mouth Paint
Ford Peter R
|
Jan/Feb 1999
Pg. 48
|
Misoprostol Mucoadhesive Anesthetic Powder
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 49
|
Potassium Nitrate Desensitizing Gel
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 50
|
Tetracycline 2.4% or Metronidazole 10% Periodontal Gel
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 51
|
Antioxidants, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 52-55
|
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 56-57
|
Calculations
Prince Shelly J
|
Jan/Feb 1999
Pg. 58
|
Stability of Four Commercial Products Delivered by Mail Order
Hadzija Boka W, Shrewsbury Robert P
|
Jan/Feb 1999
Pg. 59-63
|
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital
English Brett A, Riggs Robert M, Webster Andrew A, Benner Kimberly W
|
Jan/Feb 1999
Pg. 64-66
|
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature
Lieu Cynthia L, Chin Alfred, Gill Mark A
|
Jan/Feb 1999
Pg. 67-68
|
